跳至主要内容
临床试验/DRKS00029960
DRKS00029960已完成未知

Hydrotherapy and acupressure in restless legs syndrome – a randomized, controlled, three-armed, explorative clinical trial - HYDRAC

Charité - Universitätsmedizin BerlinInstitut für Sozialmedizin, Epidemiologie und Gesundheitsokönomie0 个研究点目标入组 54 人开始时间: 2022年8月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. age between 18 years and 70 years
  • 2. presence of a diagnosis of idiopathic RLS confirmed by a specialist.
  • 3. subjective intensity of RLS symptoms greater than or equal to 30 on a visual analogue scale of 0-100 mm in the last 7 days before inclusion.
  • 4. no planned change in medication during the study period.
  • 5. at least moderate RLS symptoms (IRLS - total score = 11 on a severity scale validated by the International Restless Legs Syndrome Study Group (IRLS)).
  • 6. willingness of the patient to be randomised and to take part in the examinations within the framework of the study or to complete questionnaires/diaries.
  • 7. the patient is capable of giving consent and is cognitively and linguistically able to understand the significance of the study.
  • 8. signed informed consent form.

排除标准

  • 1. known secondary restless legs syndrome
  • 2. regular use of medications that cause restless legs syndrome
  • 3. use of hydrotherapy, acupuncture or acupressure in the last 4 weeks before inclusion or planned in the next 12 weeks.
  • 4. acute infection with the SARS-COV-2 virus or presence of a long-COVID syndrome as well as positive SARS-COV-2 test according to the currently valid regulations of the Charité.
  • 5. for women: Pregnancy or breastfeeding.
  • 6. presence of a serious acute and/or chronic organic or serious mental illness that does not allow participation in the study intervention.
  • 7. medication, drug and/or alcohol abuse.
  • 8. treatment with opioids.
  • 9. participation in an intervention study during the same period of the study or in the last 3 months before the start of the study for this condition.
  • 10. advanced cardio/pulmonary disease (NYHA/GOLD III+IV).
  • 11. dependence on the study centre (e.g. employed).
  • 12. known Raynaud's disease and advanced circulatory disorders of the extremities.
  • 13. known cold agglutinin disease.
  • 14. inadequately treated dermatological disease in the treatment area (large wounds, severe neurodermatitis, severe psoriasis, etc.).

研究者

发起方
Charité - Universitätsmedizin BerlinInstitut für Sozialmedizin, Epidemiologie und Gesundheitsokönomie

相似试验